Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
12000 participants
OBSERVATIONAL
2003-12-31
2030-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Once the data has been collected, investigators will run a variety of statistical analyses to which will help us to learn more about the factors that cause various cardiovascular diseases such as coronary heart disease, angina, heart failure, hypertension, and stroke. The statistical analyses will also help us to understand how these diseases can be treated more effectively.
By collecting a large amount of data on a large number of cardiovascular patients, investigators will be able to analyze, with a great deal of precision, those factors that influence the onset, course, and treatment of cardiovascular disease. The results of these precise analyses can then be used to help optimize clinical efforts to prevent and treat cardiovascular disease.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients
NCT03444259
Assessment of Translesional Markers and Metabolomics
NCT00321139
China Acute Myocardial Infarction Registry
NCT01874691
Cardiovascular Health Improvement Project
NCT02306200
Myocardial Contrast Echocardiography for the Assessment of the Infarct Related Artery & Risk Area in Patients w/ NSTEMI.
NCT02014701
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the present study, investigators intend to establish a large database of cardiovascular patients. More specifically, investigators will create a database of approximately 12,000 cardiac catheterization and heart failure patients from Emory University Hospital, the Emory Clinic, Emory University Hospital Midtown, Grady Memorial Hospital, Atlanta VA Medical Center, Organized/Planned Community Events in the Atlanta Metropolitan area, held at places of Worship, local Community Centers, shopping Malls, doctor's Offices and Health Clinics and any other miscellaneous locations, e.g. Parks, Leisure centers, Conference centers.
Investigators will collect a large amount of data on these patients. Data to be collected will include information on:
Medical record data, including imaging Patient questionnaire data DNA and other biochemical data obtained and/or generated from patient blood samples or cheek (buccal) swabs Non-invasive measurements of blood pressure, heart rate and studies relating to assessment of the health of arteries
The data noted above will be collected by:
administering questionnaires/interviews to the patients accessing the medical records of the patients collecting blood samples from patients which will be analyzed by laboratories for their biochemical content.
Once the data has been collected, investigators will run a variety of statistical analyses to which will help us to learn more about the factors that cause various cardiovascular diseases such as coronary heart disease, angina, heart failure, hypertension, and stroke. The statistical analyses will also help investigators to understand how these diseases can be treated more effectively.
How the Research Will Advance Scientific Knowledge/Human Health:
By collecting a large amount of data on a large number of cardiovascular patients, investigators will be able to analyze, with a great deal of precision, those factors that influence the onset, course, and treatment of cardiovascular disease. The results of these precise analyses can then be used to help optimize clinical efforts to prevent and treat cardiovascular disease.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients with active cardiovascular disease including but not limited to
1. Ischemic Heart Disease
2. Heart Failure and Cardiomyopathies
3. Peripheral Vascular Disease
4. Valve disease
5. Adult Congenital Heart disease
6. Electrophysiological Disorders
3. Any Atlanta metropolitan area resident aged 18 and above in satisfactory physical health and able to tolerate a blood draw or buccal swab.
Exclusion Criteria
2. Blood transfusions within past 3 weeks
3. Active Cancer (non-skin cancers)
4. Enrollment against doctor recommendation
5. Patient not able to provide consent including but not limited to:
1. Intubated and critically unwell patients
2. Dementia
3. Alzheimer's disease
4. Moderate to severe alcohol or drug abuse
5. Against religious beliefs (e.g. Jehovah's witness
20 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Emory University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Arshed A. Quyyumi
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arshed A Quyyumi, MD
Role: PRINCIPAL_INVESTIGATOR
Emory School Of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Emory School Of Medicine
Atlanta, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
950-2003
Identifier Type: OTHER
Identifier Source: secondary_id
IRB00000343
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.